🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Fantastic course on #researchcommunication and #impact by the postdoctoral program at UiO - Det medisinske fakultet. Already taking small steps to implement what we learned about these past two days. Audun Farbrot

Congratulations to #PRIMA team on being awarded Centre of Excellence by Norges forskningsråd and cheers to great science and collaborations ahead!

Great opportunity, 2 open postdoc positions in computational biology to identify signatures of immunosuppression in cancer at Myklebust Lab, and 2 more positions in PRIMA, see nature.com/naturecareers/… and nature.com/naturecareers/…  Please share!

Great talk again on the diversity of intratumoral Tregs in B-cell NHL presented by Ivana Spasevska from Oslo

Activated intratumoral Tregs could limit clinical responses to immunotherapy and identifying and targeting their vulnerabilities has the potential to improve anti-tumor immune responses. Tregs could be an attractive target for immunomodulation #17icml #CureFL #follicularlymphoma

Beautiful trial presented by Sirpa Leppa: biomarker-driven 1L treatment in high-risk LBCL (NLG-LBC-06) R-DA-EPOCH-R may overcome the adverse impact of biological risk factors, apart from TP53 alterations & ctDNA burden 🧬 EOT ctDNA MRD predicts OS and complements PET #17ICML

Excellent presentation by Ivana Spasevska today at #17ICML, presenting our study Diversity of immunosuppressive regulatory T cells in B-cell lymphoma @Kreftforeningen Norges forskningsråd Oslounivsykehus

Are there several subsets of regulatory T cells (Tregs) in B-cell lymphoma and which subset might limit the efficacy of cancer immunotherapy? We explored the diversity of Tregs by several orthogonal single-cell technologies, now online in Blood Advances pubmed.ncbi.nlm.nih.gov/37695745/

Excellent presentation by Kanutte Huse at #ASH oral session 622, presenting our study "Reduced Immune cell infiltration in MHC class I negative DLBCL". @Kreftforeningen Precision Immunotherapy Alliance UiO - Det medisinske fakultet

Thea J Christensen defended her Master thesis today! Ivana Spasevska and I are very proud supervisors! Myklebust Lab. Big thank to sensors @SigridSkanland and Kristian Pryds for excellent discussion!

So proud of Thea Josefine and the team for winning the poster prize at the NBS contact meeting! Myklebust Lab

Happy to share our work Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-cell Lymphoma just published online in Blood Cancer Discovery aacrjournals.org/bloodcancerdis… Thank you for fantastic team work Leo Meriranta & Selma Sorri and collaboration Myklebust Lab Varjosalo_Lab

Exited to share our study on multi-omics profiling in follicular lymphoma, excellently led by B. Bai and Jillian Wise,PhD, now out in Blood Cancer J, doi.org/10.1038/s41408…

Ful Ruso-Julve at #ECI2024 shares his work on engineering long-acting biologics! His poster has also been nominated for best poster🥳🤞

Friends! I am super-excited to share our story on KLHL6 in this @BCD_aacr 📣KLHL6 targets the B-cell receptor and lymphoma mutations perturb this homeostasis! 🔓Read doi.org/10.1158/2643-3… 🪩Joint editorial in Cancer Discovery doi.org/10.1158/2159-8… 🧵Let’s go

Big congratulations to our Finnish collaborators Leo Meriranta Sirpa Leppa on their latest research article about KLHL6! We’re honored to have been part of this incredible work.

It's been a great pleasure to attend #ECI2024 in Dublin and an honor to present our research on cytotoxic CD4 T cells in B cell lymphoma. Fantastic meeting filled with many inspiring talks and virbrant discussions. Myklebust Lab Precision Immunotherapy Alliance Norwegian Society for Immunology